tesofensine and tirzepatide together Capsules 500mcg 30ct - Research Grade Tesofensine | TNS2330 triple monoamine

You may be suitable for treatment if you: Are aged 18 years or over Have a Body Mass Index (BMI) of 30 or above Have a BMI of 27 or above with eligible weight-related health conditions Are looking for additional support with weight management Have found it difficult to achieve sufficient weight loss through lifestyle changes alone All patients must complete a clinical assessment before treatment can be prescribed

doi: 10.1073/pnas.70.10.2804

Approved in April 2026, it's designed for maximum flexibility

The financial picture for these medications reveals significant disparities in both brand-name pricing and availability of compounded alternatives

When my patients stick to a more plant-based diet, they end up losing a significant amount of weight

Based on preliminary preclinical research, BPC-157